Tim Geach

发表

Rehabilitation: Smartphone-based cardiac rehabilitation—a first RCT

Tim Geach, 2014, Nature Reviews Cardiology.

Hypertension: The Symplicity of renal denervation

Tim Geach, 2014, Nature Reviews Nephrology.

Dyslipidaemia: Active BAT reduces atherosclerosis

Tim Geach, 2015, Nature Reviews Endocrinology.

NASH: Pioglitazone safe and effective for treating T2DM in patients with NASH

Tim Geach, 2016, Nature Reviews Endocrinology.

Device therapy: Just IN-TIME for ICD telemonitoring

Tim Geach, 2014, Nature Reviews Cardiology.

Obesity: Mapping metabolites—specific metabolic signatures in urine are associated with adiposity

Tim Geach, 2015, Nature Reviews Endocrinology.

Coronary heart disease: NPC1L1 mutations lower CHD risk

Tim Geach, 2015, Nature Reviews Cardiology.

Heart failure: Another new PARADIGM in treatment for heart failure?

Tim Geach, 2015, Nature Reviews Cardiology.

Surgery: Low-dose aspirin and clonidine—no benefit during surgery

Tim Geach, 2014, Nature Reviews Cardiology.

Device therapy: Defibrillator-based CRT for heart failure

Tim Geach, 2014, Nature Reviews Cardiology.

Heart failure: BMD a predictor of incident heart failure

Tim Geach, 2014, Nature Reviews Cardiology.

Thyroid function: Poor thyroid function linked to NAFLD

Tim Geach, 2016, Nature Reviews Endocrinology.

Valvular disease: Improving outcomes for aortic valve replacement in the USA

Tim Geach, 2014, Nature Reviews Cardiology.

Genetics: TTR and HF in black Americans

Tim Geach, 2015, Nature Reviews Cardiology.

Genetics: APOC3 mutations lower CVD risk

Tim Geach, 2014, Nature Reviews Cardiology.

Gut microbiota: Mucin-munching bacteria modulate glucose metabolism

Tim Geach, 2017, Nature Reviews Endocrinology.

Circadian rhythms: Not a morning person? Blame it on your genes

Tim Geach, 2016, Nature Reviews Endocrinology.

Obesity: Could 13 amino acids combat obesity?

Tim Geach, 2016, Nature Reviews Endocrinology.

Diabetes: Gut microbiota improves dysglycaemia

Tim Geach, 2016, Nature Reviews Endocrinology.

Interventional cardiology: BMI inversely associated with bleeding and mortality after PCI

Tim Geach, 2015, Nature Reviews Cardiology.

Neurometabolic disease: Treating mitochondrial diseases with mTOR inhibitors—a potential treatment for Leigh syndrome?

Tim Geach, 2014, Nature Reviews Neurology.

Immunotherapy: Modified proinsulin to treat T1DM

Tim Geach, 2013, Nature Reviews Endocrinology.

Adipose tissue: Reversing age-related decline in beiging

Tim Geach, 2017, Nature Reviews Endocrinology.

Atrial fibrillation: FGF-23 associated with incident AF—a link with CKD?

Tim Geach, 2014, Nature Reviews Cardiology.

Basic research: Antifungal treatment for glioma?

Tim Geach, 2014, Nature Reviews Clinical Oncology.

Adipose tissue: New pathway in BAT activation?

Tim Geach, 2016, Nature Reviews Endocrinology.

Diabetes: New TREG gene signature for T1DM

Tim Geach, 2016, Nature Reviews Endocrinology.

Metabolism: Defects in BCAA oxidation impair lipid metabolism

Tim Geach, 2016, Nature Reviews Endocrinology.

Anticoagulation therapy: Apixaban indications set to AMPLIFY?

Tim Geach, 2013, Nature Reviews Cardiology.

Interventional cardiology: COMFORTABLE biodegradable stents in a new CENTURY?

Tim Geach, 2014, Nature Reviews Cardiology.

Neuroendocrinology: FGF21 influences a 'sweet tooth' in mice

Tim Geach, 2016, Nature Reviews Endocrinology.

Obesity: Methylation a consequence not a cause

Tim Geach, Tim Geach, 2017, Nature Reviews Endocrinology.

Basic research: FGF-21 antiobesity action independent of UCP1 and WAT browning

Tim Geach, 2015, Nature Reviews Endocrinology.

Translational medicine: β cells from stomach-derived organoids

Tim Geach, 2016, Nature Reviews Endocrinology.

Gut microbiota: Antibiotics do not affect metabolism in obesity

Tim Geach, 2016, Nature Reviews Endocrinology.